Cytomedix Inc. Appoints Martin P. Rosendale Executive Vice President and Chief Operating Officer

ROCKVILLE, Md., March 17, 2008 (PRIME NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) today announced the appointment of Martin P. Rosendale, an industry veteran with more than 25 years' experience in the biotechnology sector, to the newly created position of Executive Vice President and Chief Operating Officer.
MORE ON THIS TOPIC